Article

5 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 66, n° 4
pages 535.e1-535.e16 (avril 2012)
Doi : 10.1016/j.jaad.2011.11.961
Continuing Medical Education

Graft-versus-host disease : Part II. Management of cutaneous graft-versus-host disease
 

Sharon R. Hymes, MD a, , Amin M. Alousi, MD b, Edward W. Cowen, MD, MHSc c
a Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, Texas 
b Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas 
c Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 

Correspondence to: Sharon R. Hymes, MD, Department of Dermatology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd-434, Houston, TX 77030-4009.
Abstract

Dermatologists are ideally suited to manage the various cutaneous sequelae of graft-versus-host disease (GVHD) outlined in part I of this review. However, the complexity of the patient with GVHD, including comorbidities, potential drug interactions related to polypharmacy, and the lack of evidence-based treatment guidelines, are significant challenges to optimizing patient care. In this section, we will provide an outline for the role of the dermatologist in a multispecialty approach to caring for patients with GVHD.

The full text of this article is available in PDF format.

Key words : cyclosporine, extracorporeal photopheresis, graft-versus-host disease, hematopoietic cell transplantation, imatinib mesylate, mycophenolate mofetil, phototherapy, tacrolimus, rituximab

Abbreviations used : CNI, CSA, ECP, EV, GVHD, GVT, HCT, MMF, MSC, mTOR, MTX, NB-UVB, PUVA, PDGFR, SCC, TSS, UVA-1, UVR, Tregs, TSS



 Supported in part by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research.
 Reprints not available from the authors.

  No longer available.


© 2011  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline